Transcriptomic Biomarkers for Stress and Disease

Transcriptomics measures which genes are actively being expressed, transcribed into messenger RNA, at a given moment in a tissue sample, capturing a dynamic snapshot of an animal's current physiological state rather than its fixed, unchanging genetic sequence, making transcriptomic data fundamentally complementary to genomic marker data, which reveals what genetic potential an individual carries, by instead revealing which of that genetic potential is actually being actively used under current real conditions. Specific gene expression patterns have been identified as candidate biomarkers correlating with acute stress response, early subclinical disease before visible clinical signs appear, and general immune system activation status in several farmed species, offering the potential for earlier, more sensitive health and welfare monitoring than waiting for visible behavioral or mortality signs, a capability that connects conceptually to the broader predictive mortality and computer vision welfare monitoring approaches discussed elsewhere in this glossary but working at the underlying molecular level rather than through external observation. Practical commercial deployment of transcriptomic biomarker testing in routine farm health monitoring remains more limited than its research-stage promise might suggest, since transcriptomic analysis has historically required more specialized laboratory processing and higher per-sample cost than simpler diagnostic tests like qPCR pathogen detection, though targeted, lower-cost assays measuring just a small panel of specific, already-validated biomarker genes, rather than full transcriptome-wide analysis, are increasingly bridging this gap toward more commercially practical routine health-monitoring application. Breeding program relevance emerges where transcriptomic response patterns under a standardized stress or disease challenge test correlate with and can help explain an individual's genomic breeding value for resilience traits, potentially offering breeders additional biological insight into why certain genomic regions identified through GWAS actually influence disease resistance or stress tolerance at the underlying physiological mechanism level, beyond the purely statistical genetic association alone.